ebolaviru
caus
sever
hemorrhag
fever
human
nonhuman
primat
entri
ebolaviru
mediat
viral
glycoprotein
gp
howev
requir
host
factor
fulli
elucid
screen
util
recombin
vesicular
stomat
viru
vsv
encod
zair
ebolaviru
gp
identifi
four
chines
hamster
ovari
cho
cell
line
resist
gpmediat
viral
entri
suscept
vector
carri
sar
coronaviru
vsvg
glycoprotein
suggest
endocyt
process
pathway
util
virus
intact
cell
cathepsinactiv
form
ebolavir
glycoprotein
overcom
entri
restrict
express
sever
host
factor
previous
describ
import
ebolaviru
entri
convers
express
recent
describ
ebolaviru
host
entri
factor
niemannpick
type
restor
infect
resist
cell
encod
distinct
mutat
gene
result
loss
protein
express
studi
reinforc
import
ebolaviru
entri
ebolaviru
nonseg
negativesens
rna
viru
filovirida
famili
associ
outbreak
hemorrhag
fever
human
nonhuman
primat
subsaharan
africa
ebolaviru
infect
wide
rang
cell
type
infect
includ
macrophag
dendrit
cell
hepatocyt
entri
cell
mediat
viral
glycoprotein
gp
process
poorli
character
recent
studi
suggest
virion
enter
cell
macropinocytosi
hunt
et
al
nanbo
et
al
saeed
et
al
although
trigger
uptak
known
sever
host
factor
identifi
could
involv
step
hunt
et
al
kondratowicz
et
al
endosom
virion
encount
cystein
proteas
cathepsin
b
catb
cathepsin
l
catl
proteas
cleav
gp
within
disord
loop
chandran
et
al
kaletski
et
al
schornberg
et
al
although
cleavag
appear
necessari
entri
suffici
induc
viral
fusion
host
membran
subsequ
step
requir
cathepsin
also
necessari
kaletski
et
al
schornberg
et
al
substrat
second
cathepsin
cleavag
defin
recent
niemannpick
type
identifi
host
protein
import
entri
ebola
viru
carett
et
al
cote
et
al
thought
interact
process
form
gp
cote
et
al
mechan
action
determin
lack
knowledg
host
factor
involv
entri
ebolaviru
hinder
develop
therapeut
target
process
sever
differ
screen
strategi
use
past
identifi
host
factor
involv
entri
vari
success
chines
hamster
ovari
cell
function
haploid
cell
line
natur
genet
divers
decad
properti
cell
exploit
isol
variant
alter
specif
process
diphtheria
intox
moehr
moehr
variant
subsequ
use
elucid
mechan
given
process
studi
describ
isol
cell
line
natur
mutat
render
cell
resist
infect
mediat
ebolaviru
gp
multipl
clone
deriv
independ
select
obtain
four
chosen
character
cell
line
analyz
defect
establish
host
factor
involv
ebolaviru
entri
four
found
defect
express
exogen
express
restor
suscept
infect
four
clone
addit
overexpress
sever
purport
ebolaviru
entri
factor
overcom
defect
although
express
clone
mutat
lead
loss
express
uniqu
clone
fact
isol
multipl
clone
distinct
natur
mutat
gene
lend
weight
recent
evid
suggest
key
host
factor
necessari
entri
ebolaviru
isol
clone
resist
gpmediat
entri
replic
compet
vsv
encod
ebolaviru
zair
zebov
gp
mcherri
place
vsv
g
construct
cellular
entri
recombin
viru
vsv
ebogp
mcherri
mediat
ebolavir
glycoprotein
similar
previous
describ
vaccin
viru
vsvdgzebov
gp
feldmann
et
al
garbutt
et
al
jone
et
al
ebolaviru
gp
requir
entri
confirm
loss
infect
presenc
lysosomotrop
reagent
catband
catlspecif
inhibitor
data
shown
infect
suscept
cell
recombin
viru
result
effici
kill
basi
select
strategi
employ
function
haploid
cell
line
use
identifi
cell
resist
infect
vsv
ebogp
mcherri
use
strategi
outlin
fig
infect
unmutagen
cho
cell
vsv
ebogp
mcherri
moi
produc
numer
coloni
contrast
infect
vsvgfp
vsv
vector
express
glycoprotein
gfp
marker
produc
viabl
coloni
observ
suggest
high
level
natur
resist
ebolavir
entri
cho
cell
expans
coloni
pool
clone
limit
dilut
clonal
cell
line
test
suscept
vsv
ebogp
mcherri
vsv
gfp
four
clonal
cell
line
display
complet
resist
vsv
ebogp
mcherri
maintain
suscept
vsv
gfp
chosen
character
four
cell
line
deriv
resist
coloni
isol
separ
plate
challeng
vsv
ebogp
mcherri
cell
line
display
similar
morpholog
wildtyp
wt
cell
cell
much
larger
wt
cell
fibroblastlik
appear
cell
larger
rounder
parent
suscept
profil
clone
confirm
examin
express
mcherri
gfp
via
light
microscopi
vari
time
point
postinfect
pi
vsv
ebogp
mcherri
vsv
gfp
respect
data
shown
begin
h
pi
gfp
visibl
wt
cell
infect
vsv
gfp
h
pi
cell
infect
show
cytopath
effect
vsv
replic
infect
wt
cell
vsv
ebogp
mcherri
produc
similar
pattern
contrast
cell
line
neither
express
mcherri
marker
cytopath
effect
vsv
replic
seen
either
high
low
moi
vsv
ebogp
mcherri
time
point
h
postinfect
given
rapid
kinet
vsv
replic
cell
even
low
level
infect
would
appar
h
quantit
analysi
use
flow
cytometri
demonstr
four
cell
line
effect
infect
vsv
gfp
fig
contrari
averag
wt
cell
express
mcherri
h
challeng
vsv
ebogp
mcherri
less
cell
express
mcherri
fig
data
indic
cell
resist
infect
mediat
zair
ebolaviru
gp
vsv
g
clone
resist
transduct
hiv
pseudotyp
bear
zebov
gp
vsv
g
ensur
resist
clone
specif
gpmediat
entri
examin
whether
clone
suscept
transduct
hiv
pseudotyp
encod
gfp
bear
vsv
g
hivvsv
g
zair
ebolaviru
gp
hiv
zebov
gp
cell
fix
h
pi
analyz
flow
cytometri
gfp
express
four
resist
clone
similar
level
transduct
hivvsv
g
wt
cell
determin
percent
cell
express
gfp
fig
contrast
averag
approxim
wt
cell
express
gfp
follow
transduct
hivzebov
gp
less
resist
cell
transduc
repres
less
ten
percent
level
transduct
wt
cell
fig
similar
result
seen
resist
cell
challeng
hiv
pseudotyp
bear
sudan
ebolaviru
sebov
gp
cote
divoir
ebolaviru
ciebov
gp
reston
ebolaviru
rebov
gp
fig
statist
signific
differ
level
infect
cell
line
compar
across
filovir
glycoprotein
taken
togeth
data
indic
resist
infect
observ
cell
specif
filovir
gpmediat
entri
ebolaviru
gp
normal
process
endosom
cathepsin
entri
host
cell
cleavag
believ
necessari
activ
fusogen
potenti
gp
test
whether
resist
infect
isol
cho
cell
line
due
defect
upstream
ebolaviru
gp
proteolysi
step
challeng
resist
cell
hiv
pseudotyp
bear
mutant
form
gp
mimic
process
gp
gp
fig
mutant
form
gp
contain
furin
recognit
sequenc
rrkr
amino
acid
fig
presenc
furin
gp
cleav
amino
acid
produc
fragment
six
amino
acid
longer
catl
process
speci
hood
et
al
cell
transduc
hivzebov
gp
pseudotyp
encod
gfp
analyz
flow
cytometri
although
gp
incorpor
hiv
virion
ratio
approxim
compar
wt
gp
pseudotyp
bear
gp
infecti
see
fig
wt
cell
increas
suscept
wt
cell
hivzebov
gp
averag
cell
infect
compar
wt
gp
seen
resist
cell
line
lack
increas
suscept
resist
cell
line
indic
resist
infect
seen
cell
line
could
overcom
prior
cleavag
ebolaviru
gp
fig
determin
whether
cell
line
resist
due
reduc
viral
bind
cell
surfac
perform
bind
assay
hivvsv
g
hivzebov
gp
viru
spun
onto
cell
follow
wash
cold
pb
remov
unbound
viru
prior
lyse
cell
cell
lysat
analyz
quantit
western
blot
hiv
level
compar
viral
input
control
level
bind
hivvsv
g
hiv
zebov
gp
pseudotyp
cell
line
statist
signific
compar
wt
cell
fig
indic
bind
effici
alter
resist
cell
cell
line
express
activ
form
cathepsin
b
cathepsin
l
remain
resist
ebolaviru
entri
mention
filovirus
requir
cleavag
gp
catb
andor
catl
infect
cell
therefor
test
whether
cell
line
resist
gpmediat
infect
due
loss
express
catb
catl
cell
transfect
human
catb
human
catl
express
plasmid
challeng
vsv
ebogp
mcherri
analyz
flow
cytometri
fig
repres
combin
result
three
separ
experi
percent
cell
express
mcherri
similar
background
level
condit
resist
cell
line
two
three
experi
small
statist
signific
increas
infect
cell
compar
empti
vector
catl
transfect
cell
fig
howev
percent
cell
express
mcherri
still
less
suggest
minor
increas
like
biolog
relev
lack
infect
cell
presenc
overexpress
catb
catl
indic
loss
express
catb
catl
caus
resist
gpmediat
infect
howev
analysi
rule
possibl
cell
lack
abil
activ
catb
catl
activ
catb
catl
requir
two
sequenti
process
step
procathepsin
form
doubl
chain
form
three
form
protein
procathepsin
pro
singl
chain
sc
fulli
activ
doubl
chain
dc
visual
western
blot
analysi
use
cathepsin
antibodi
determin
whether
cell
capabl
process
cathepsin
activ
form
lysat
cell
transfect
human
catb
catl
express
plasmid
analyz
western
blot
transfect
cell
express
three
form
human
catb
indic
catb
fulli
process
cell
fig
antibodi
catl
recogn
human
hamster
catl
therefor
band
pattern
western
blot
complex
howev
seen
fig
four
resist
clone
clearli
express
activ
form
endogen
catl
togeth
data
suggest
cell
process
catb
catl
activ
form
similar
filovirus
sever
acut
respiratori
syndrom
sar
coronaviru
cov
requir
cleavag
glycoprotein
spike
catl
enter
cell
simmon
et
al
therefor
directli
address
whether
cathepsin
pathway
cell
function
activ
viral
glycoprotein
challeng
ebolaviru
resist
clone
vsv
pseudotyp
encod
luciferas
bear
sarscov
zebov
gp
chines
hamster
cell
lack
function
surfac
receptor
sarscov
accordingli
ebolavirusresist
cell
line
transient
transfect
express
plasmid
human
receptor
sarscov
h
prior
transduct
vsvsar
vsvzebov
gp
untransfect
cell
also
challeng
vsvsar
neg
control
cell
express
display
high
level
luciferas
activ
follow
challeng
vsvsar
fig
convers
cell
line
refractori
transduct
mediat
ebolaviru
gp
background
level
luciferas
activ
seen
follow
challeng
vsvzebov
gp
background
luciferas
valu
mutant
cell
line
statist
differ
compar
seen
vsvsar
transduct
absenc
human
high
level
transduct
four
clone
vsvsar
indic
endosom
uptak
catl
pathway
intact
appear
mechan
resist
cell
line
addit
cathepsin
sever
host
factor
identifi
potenti
import
ebolaviru
gpmediat
entri
includ
axl
kondratowicz
et
al
shimojima
et
al
shimojima
et
al
determin
ebolavirusresist
cell
line
defect
either
protein
transfect
wt
cell
express
plasmid
axl
express
axl
confirm
cell
subsequ
infect
vsv
ebogp
mcherri
analyz
flow
cytometri
similar
earlier
result
seen
overexpress
catb
catl
level
infect
ebolaviru
resist
cell
line
statist
signific
compar
cell
express
axl
versu
empti
vector
fig
indic
defect
express
axl
like
caus
resist
clone
moreov
express
factor
compens
deficit
ebolavirusresist
cell
recent
endosomalresid
protein
shown
import
ebola
infect
carett
et
al
cote
et
al
therefor
analyz
resist
cell
line
defect
express
express
fulllength
readili
evid
western
blot
analysi
wt
cell
fig
wherea
express
seen
four
ebolavirusresist
cell
line
determin
basi
loss
express
resist
cell
perform
rtpcr
total
cellular
rna
sequenc
analysi
cdna
three
clone
reveal
contain
uniqu
frameshift
mutat
gene
cell
line
encod
nt
duplic
exon
start
nt
result
truncat
protein
predict
amino
acid
long
cell
line
contain
insert
exon
flank
repeat
see
fig
insert
result
predict
aa
product
contain
substitut
exon
delet
exon
delet
result
truncat
protein
residu
number
rtpcr
analysi
use
sever
set
primer
fail
detect
intact
transcript
encod
cell
line
suggest
larg
delet
major
rearrang
locu
cell
establish
whether
loss
express
cell
line
caus
ebolavirusresist
phenotyp
gener
cell
stabli
express
human
lentivir
vector
encod
hygromycin
b
resist
gene
gfp
use
transduc
parent
wt
four
resist
cell
line
hygromycin
b
select
cell
use
protein
analysi
western
blot
challeng
vsv
ebogp
mcherri
analyz
flow
cytometri
vari
readili
detect
level
seen
hygromycin
select
cell
line
fig
case
stabl
express
abl
least
partial
restor
suscept
ebolaviru
gpmediat
infect
fig
transduc
cell
line
infect
vsv
ebogp
mcherri
roughli
wt
cell
fig
restor
suscept
less
effici
line
averag
infect
level
wt
level
still
seen
without
express
similar
trend
clone
show
lowest
degre
restor
seen
cell
transient
express
data
shown
comparison
stabl
express
cell
cho
cell
line
carri
delet
locu
millard
et
al
result
level
infect
wt
cell
basi
vari
degre
suscept
transduc
cell
unclear
result
demonstr
restor
express
cell
line
confer
suscept
ebolaviru
infect
multipl
screen
strategi
includ
genet
complement
compar
gene
express
analysi
use
past
identifi
host
factor
import
entri
ebolaviru
often
result
ambigu
modest
increas
infect
seen
presenc
host
factor
instanc
predict
host
factor
express
suscept
cell
type
chan
et
al
kondratowicz
et
al
studi
employ
altern
approach
select
natur
mutat
render
cell
normal
suscept
infect
resist
cell
function
haploid
allel
mutat
singl
allel
gene
like
result
phenotyp
effect
affect
protein
mutagen
cell
prior
select
limit
screen
natur
occur
mutat
disrupt
function
vital
viral
entri
also
increas
likelihood
select
genet
variant
mutat
singl
gene
four
independ
cell
line
demonstr
complet
resist
infect
vsv
ebogp
mcherri
identifi
select
character
previous
anoth
clone
cho
also
shown
resist
ebolaviru
gpmediat
entri
schornberg
et
al
resist
attribut
defect
process
catb
catl
caus
lack
express
integrin
cell
surfac
unlik
cho
cell
cell
line
express
activ
dc
form
catb
catl
furthermor
cell
line
suscept
infect
pseudotyp
bear
sar
cov
spike
protein
confirm
endosom
intern
catl
function
cell
although
slight
albeit
statist
signific
increas
suscept
cell
line
vsv
ebogp
mcherri
human
catl
overexpress
level
infect
still
less
one
percent
suggest
increas
biolog
relev
sever
host
factor
addit
catl
catb
identifi
previous
import
gpmediat
entri
ebola
includ
axl
kondratowicz
et
al
shimojima
et
al
shimojima
et
al
overexpress
protein
resist
cell
line
restor
suscept
suggest
cell
defect
either
gene
recent
evid
demonstr
axl
facilit
entri
virus
mediat
mechan
resembl
apoptot
bodi
uptak
process
evid
primari
entri
pathway
disrupt
impair
morizono
et
al
axl
also
provid
altern
entri
pathway
lassa
viru
cell
defici
primari
receptor
adystroglycan
process
requir
shimojima
et
al
result
indic
axl
overexpress
provid
altern
mean
entri
defici
ebolavirusresist
mutant
cell
line
entri
target
cell
ebolaviru
like
use
multipl
host
factor
accomplish
step
attach
uptak
traffick
fusion
defect
host
protein
involv
step
could
potenti
confer
cellular
resist
infect
consequ
rel
unbias
select
method
employ
could
result
isol
mutant
defect
sever
differ
gene
seen
similar
screen
look
diphtheria
toxin
resist
moehr
moehr
howev
four
independ
isol
ebolaviru
gpresist
cho
cell
line
contain
mutat
gene
although
resist
cell
line
character
mutat
mutat
uniqu
indic
aros
discret
event
furthermor
exogen
express
restor
suscept
resist
cell
indic
loss
express
suffici
render
cell
resist
possibl
resist
cell
line
could
addit
defect
anoth
gene
howev
given
high
level
restor
seen
exogen
express
mutat
like
play
minor
role
suscept
entri
recent
two
group
independ
identifi
key
compon
ebolaviru
gpmediat
infect
carett
et
al
cote
et
al
carett
et
al
use
insert
mutagenesi
approach
identifi
cell
resist
infect
ebolaviru
gp
although
util
recombin
vsvebogp
vector
similar
one
employ
insert
mutagenesi
strategi
employ
could
bias
result
toward
larg
target
size
kilobas
gene
similarli
studi
cote
colleagu
use
compound
librari
screen
identifi
thu
bias
toward
druggabl
target
find
use
select
strategi
bia
natur
occur
mutat
also
identifi
multipl
ebolavirusresist
cell
line
despit
perform
select
screen
vsvebogp
use
four
independ
pool
cell
contrast
select
screen
carett
et
al
current
studi
identifi
target
ebolaviru
entri
asid
fact
screen
identifi
hop
hemolyt
fusion
protein
sort
endosom
sort
complex
protein
found
carett
et
al
may
suggest
cho
cell
defect
gene
rare
screen
satur
taken
whole
three
strategi
differ
select
bia
identifi
host
factor
confirm
critic
role
ebola
entri
import
player
cholesterol
homeostasi
acid
protein
predict
membranespan
domain
normal
local
within
late
endosom
mutat
analysi
human
patient
reveal
differ
alter
wide
distribut
throughout
gene
affect
cholesterol
regulatori
function
carstea
et
al
garver
heidenreich
major
missens
mutat
sever
result
essenti
normal
amount
protein
impair
cholesterol
control
ribeiro
et
al
missens
delet
mutat
affect
local
late
endosom
also
identifi
blom
et
al
howev
studi
cho
mutant
select
resist
ebolaviru
gp
abrog
protein
express
suggest
simpl
mutat
impair
cholesterol
regulatori
function
crippl
protein
role
ebolavir
entri
demonstr
cho
cell
select
resist
infect
mediat
ebolaviru
glycoprotein
harbor
defect
four
independ
cell
line
examin
mutat
within
gene
aborg
express
protein
restor
protein
express
restor
sensit
ebolaviru
gp
mediat
infect
result
underscor
import
ebolavir
entri
cell
cultur
plasmid
cell
maintain
kaighn
modifi
nutrient
mixtur
heatinactiv
fetal
bovin
serum
fb
lglutamin
penicillin
streptomycin
cell
kindli
provid
daniel
ori
millard
et
al
bhk
cell
maintain
eagl
minimum
essenti
medium
mem
fb
penicillin
streptomycin
vero
cell
maintain
high
glucos
dulbecco
modifi
eagl
medium
dmem
fb
penicillin
streptomycin
cultur
grown
co
strain
zair
mayinga
g
gp
pcagg
sar
pspax
previous
describ
simmon
et
al
simmon
et
al
gener
site
direct
mutagenesi
plenti
cmv
gfp
hygro
hcathepsinl
hcathepsinb
obtain
addgen
cambridg
cdna
obtain
open
biosystem
clone
plko
pcr
rluc
vsvl
vsvn
vsvp
express
plasmid
control
promot
kindli
provid
robert
dom
ebogp
mcherri
made
overlap
extens
pcr
flank
primer
end
contain
mlui
restrict
site
use
amplifi
ebolaviru
zair
gp
flank
primer
end
contain
nhei
restrict
site
use
amplifi
mcherri
intern
primer
design
addit
junction
sequenc
flank
kpni
xhoi
insert
gp
mcherri
rluc
gene
remov
rluc
cleavag
mlui
nhei
replac
gpkpnijunctionxhoimcherri
sequenc
plenti
cmv
hygro
construct
remov
gfp
gene
plenti
cmv
gfp
hygro
insert
place
cdna
origen
axl
clone
id
open
biosystem
furin
previous
describ
simmon
et
al
woollewi
bate
vsv
ebogp
mcherri
gener
use
protocol
similar
describ
lawson
et
al
follow
chang
lawson
et
al
briefli
earli
passag
bhk
cell
infect
modifi
vaccinia
ankara
gift
bernard
moss
min
cell
transfect
ebogp
mcherri
pvsvn
pvsvl
pvsvp
use
lipofectamin
invitrogen
three
day
posttransfect
cell
scrape
dish
cell
supernat
subject
three
round
freezethaw
result
mixtur
spun
remov
cellular
debri
pass
um
filter
ad
bhk
cell
clarifi
filter
supernat
passag
onto
bhk
cell
two
addit
time
three
round
infect
bhk
cell
supernat
transfer
vero
cell
along
neutral
antibodi
kindli
provid
gari
cohen
roz
eisneberg
vaccinia
antibodi
includ
two
addit
passag
vero
cell
ensur
remov
mva
work
stock
vsv
ebogp
mcherri
vsv
gfp
expand
vero
cell
grown
cm
roller
bottl
supernat
clarifi
centrifug
min
follow
ultracentrifug
rpm
rotor
min
supernat
transfer
new
tube
concentr
sucros
cushion
ultracentrifug
rpm
two
hour
rotor
viral
pellet
resuspend
hepesbuff
salin
hb
overnight
store
concentr
viral
stock
determin
plaqu
assay
vero
cell
vsv
gfp
kindli
provid
sara
cherri
cell
plate
cm
plate
confluenc
cell
infect
vsv
ebogp
mcherri
moi
plate
maintain
three
week
resist
coloni
contain
cell
coloni
transfer
plate
use
steril
paper
disc
soak
trypsin
cell
allow
grow
confluenc
replat
approxim
one
cell
per
well
plate
clone
expand
challeng
separ
vsv
ebogp
mcherri
vsv
gfp
four
cell
line
origin
resist
coloni
isol
separ
cm
plate
chosen
analysi
make
human
immunodefici
viru
hiv
pseudotyp
cell
transfect
use
standard
calcium
phosphat
method
mg
hiv
vector
pspax
mg
plenti
cmv
gfp
hygro
either
mg
g
mg
pcaggsebola
hivzebov
gprrkr
mg
pspax
mg
plenti
cmv
gfp
hygro
mg
pcaggsebola
mg
furin
use
viral
supernat
collect
h
posttransfect
concentr
sucros
cushion
ultracentrifug
rpm
rotor
h
pellet
resuspend
hb
overnight
incorpor
ebolaviru
glycoprotein
determin
quantit
western
blot
either
polyclon
rabbit
antibodi
bethyl
polyclon
rabbit
antiserum
vsv
pseudotyp
made
graham
simmon
previous
describ
ray
et
al
briefli
cell
transfect
pcagg
sar
gp
h
prior
infect
vsvdg
virion
deriv
rluc
supernat
harvest
h
postinfect
filter
mm
filter
store
infect
done
triplic
cell
plate
plate
equival
densiti
vsv
ebogp
mcherri
vsv
gfp
plaqu
form
unit
pfu
respect
ad
well
cell
fix
h
later
analyz
flow
cytometri
mcherri
gfp
express
hiv
pseudotyp
cell
transduc
equival
amount
viru
base
quantit
western
blot
antibodi
specif
nih
aid
research
refer
program
cat
cell
fix
h
postchalleng
analyz
flow
cytometri
gfp
express
cell
detach
plate
phosphatebuff
salin
lack
ca
mg
contain
mm
edta
cell
pellet
min
rpm
resuspend
flow
wash
buffer
bovin
calf
serum
sodium
azid
paraformaldehyd
sampl
event
collect
use
becton
dickinson
lsrii
analyz
use
flowjo
softwar
tree
star
inc
cho
cell
grown
confluenc
plate
cool
equival
amount
particl
base
hiv
level
spun
onto
cell
min
cell
wash
twice
cold
pb
lyse
ml
lysi
buffer
triton
mm
tri
ph
mm
edta
mm
nacl
complet
proteas
inhibitor
cocktail
roch
lysat
clear
centrifug
rpm
min
entir
lysat
mix
reduc
sd
buffer
boil
min
separ
criterion
page
gel
biorad
protein
transfer
pvdf
membran
millipor
membran
probe
monoclon
antibodi
protein
detect
goat
antimous
rockland
view
licor
odyssey
scanner
determin
percent
input
viru
bound
cell
level
lysat
compar
level
lane
contain
amount
viru
initi
ad
well
cell
overexpress
assay
catl
catb
axl
wt
resist
cell
plate
transfect
mg
hcathepsinl
hcathepsinb
axl
plko
use
lipofectamin
ltx
plu
reagent
cell
replat
plate
h
posttransfect
h
posttransfect
cell
infect
vsv
ebogp
mcherri
cell
fix
h
postinfect
analyz
flow
cytometri
mcherri
express
protein
express
confirm
western
blot
use
antibodi
specif
catl
catb
athen
research
technolog
axl
r
system
wt
resist
cho
clone
challeng
hiv
pseudotyp
bear
vsv
g
contain
plenti
cmv
hygro
vector
h
postinfect
transduc
cell
select
mgml
hygromycin
b
stabl
hygromycinresist
cell
subsequ
infect
vsv
ebogp
mcherri
analyz
flow
cytometri
describ
wt
resist
cell
plate
transfect
mg
use
lipofectamin
ltx
plu
reagent
transfect
cell
replat
plate
h
later
infect
equal
amount
vsvzebov
gp
vsvsar
supernat
triplic
h
posttransfect
h
postinfect
media
remov
well
replac
ul
renilla
luciferas
assay
lysi
buffer
promega
plate
rock
min
lysat
transfer
new
well
contain
ml
renilla
luciferas
assay
reagent
luminesc
measur
luminoskan
ascent
thermo
electron
corpor
ascent
softwar
luciferas
bind
assay
data
analyz
repeat
measur
twoway
anova
bonferroni
posttest
use
graphpad
prism
softwar
data
analyz
permut
test
signific
cut
p
number
permut
calcul
rang
